The NanoAssemblr®️ Spark™️ | Robust Low Volume RNA-Lipid Nanoparticle Formulation

Sdílet
Vložit
  • čas přidán 15. 03. 2022
  • Develop RNA-lipid nanoparticles (LNPs) in under 10 seconds for drug discovery and early preclinical development. The NanoAssemblr®️ Spark™️ instrument enables rapid µL formulations to conserve limited and expensive ingredients with minimal waste. The proprietary NxGen™️ microfluidic technology enables controlled and reproducible manufacturing of homogenous LNPs.
    Learn more about the system: www.precisionn...
    Follow us on LinkedIn: bit.ly/3F9uEiL
    Follow us on Twitter: bit.ly/3yBttpW
  • Věda a technologie

Komentáře •